Virtual reality relaxation program can reduce pain intensity, with significant changes in brain functional connectivity patterns.

SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.

Enfortumab vedotin plus pembrolizumab is more effective than chemotherapy as first-line treatment for metastatic urothelial cancer, data suggest.

Converting from the long-acting ESA methoxy polyethylene glycol-epoetin-ß (MPG-EPO) to thrice weekly vadadustat is feasible for the hemodialysis population.

Adding pembrolizumab to docetaxel did not significantly improve outcomes in previously treated patients with mCRPC.

(HealthDay News) — Despite increased participation in U.S. long-distance running races, cardiac arrest incidence remains stable, according to a study published online March 30 in the Journal of the ...

(HealthDay News) — Microplastic exposure may increase the risk for chronic diseases, according to a study presented at the annual meeting of the American College of Cardiology, held from March 29 to ...

Findings from the APPEAR-C3G trial showed a 35% reduction in 24-hour UPCR from baseline (primary endpoint) in the iptacopan group compared with the placebo group. The Food and Drug Administration ...

The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

Patients with secondary rectal cancer after prostate cancer radiation therapy may have worse survival than patients with primary rectal cancer. Secondary rectal cancer after prostate cancer ...